Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
Novocure
  • News

Novocure to Showcase Tumor Treating Fields at Leerink Global Healthcare Conference

  • The Pharma Data
  • March 2, 2026

Novocure’s Leadership to Highlight Innovative Cancer Therapy at Prestigious Event Why should healthcare investors and oncology professionals be paying attention to Novocure’s upcoming participation in the Leerink Global Healthcare Conference?…

Read MoreNovocure to Showcase Tumor Treating Fields at Leerink Global Healthcare Conference
Cryo-Cell
  • BusinessPress Releases

Cryo-Cell International Reports Fiscal 2025 Results: Revenue Declines, Net Loss Recorded

  • The Pharma Data
  • March 2, 2026

Cryo-Cell International Sees Revenue Dip and Net Loss in Fiscal 2025 What does a year of financial downturn mean for the world’s first private cord blood bank? Cryo-Cell International, Inc.…

Read MoreCryo-Cell International Reports Fiscal 2025 Results: Revenue Declines, Net Loss Recorded
Guardant Health
  • Press Releases

Guardant Health Grants Equity Awards to New Non-Executive Employees

  • The Pharma Data
  • March 2, 2026

Strategic Equity Incentives to Attract Talent and Drive Innovation Why is attracting and retaining top talent crucial for precision oncology companies? Guardant Health, a leading precision oncology company, is taking…

Read MoreGuardant Health Grants Equity Awards to New Non-Executive Employees
Prothena
  • Press Releases

Prothena Authorizes $100M Share Repurchase Plan to Enhance Shareholder Value

  • The Pharma Data
  • February 28, 2026

Prothena’s Strategic Move to Boost Shareholder Confidence and Financial Flexibility Why are biotechnology companies increasingly turning to share repurchase plans to optimize their financial strategies? Prothena Corporation plc, a late-stage…

Read MoreProthena Authorizes $100M Share Repurchase Plan to Enhance Shareholder Value
Bayer
  • News

Bayer Advances 225Ac-PSMA-Trillium for Metastatic Prostate Cancer

  • The Pharma Data
  • February 28, 2026

New Data Supports Next-Phase Development of Targeted Alpha Therapy Why is the treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) so challenging? Despite significant advances, the prognosis for men with…

Read MoreBayer Advances 225Ac-PSMA-Trillium for Metastatic Prostate Cancer
Natera's
  • Research

Natera’s Signatera MRD Advances Bladder Cancer Treatment and Patient Outcomes

  • The Pharma Data
  • February 28, 2026

New Data at ASCO GU Highlights Signatera’s Role in Bladder Preservation and Precision Medicine Why are precision medicine tools crucial for improving patient outcomes in genitourinary cancers? Natera, a global…

Read MoreNatera’s Signatera MRD Advances Bladder Cancer Treatment and Patient Outcomes
Pfizer
  • Regulatory

Pfizer and Astellas Announce Breakthrough in Muscle-Invasive Bladder Cancer Treatment

  • The Pharma Data
  • February 28, 2026

Positive Phase 3 Trial Results Signal New Standard of Care for Bladder Cancer Patients Is the current standard of care for muscle-invasive bladder cancer (MIBC) about to change? Pfizer Inc.…

Read MorePfizer and Astellas Announce Breakthrough in Muscle-Invasive Bladder Cancer Treatment
Merck
  • News

Merck’s KEYTRUDA Plus Padcev Significantly Extends Survival in Bladder Cancer

  • The Pharma Data
  • February 28, 2026

New Combination Therapy Demonstrates 47% Reduction in Event-Free Survival Events Why is this a game-changer for bladder cancer treatment? Merck, a global leader in healthcare, has announced groundbreaking results from…

Read MoreMerck’s KEYTRUDA Plus Padcev Significantly Extends Survival in Bladder Cancer
Sarepta Therapeutics
  • Press Releases

Sarepta Therapeutics Launches 2026-2027 Route 79 Duchenne Scholarship Program

  • The Pharma Data
  • February 28, 2026

Sarepta Supports Educational Ambitions of Duchenne Community with $5,000 Scholarships Why is supporting the education of individuals with Duchenne muscular dystrophy crucial for the future of rare disease treatment? Sarepta…

Read MoreSarepta Therapeutics Launches 2026-2027 Route 79 Duchenne Scholarship Program
Quanta System
  • Press ReleasesTechnology

Quanta System Inc. Expands U.S. Operations to Drive Surgical Innovation

  • The Pharma Data
  • February 28, 2026

Quanta System Establishes U.S. Entity to Enhance Market Responsiveness and Customer Engagement Why is the U.S. market pivotal for Italian companies in the medical technology sector? Quanta System Sp.A., a…

Read MoreQuanta System Inc. Expands U.S. Operations to Drive Surgical Innovation
VTAMA Cream
  • Regulatory

VTAMA Cream Shows Early and Consistent Sleep Improvements in Pediatric Atopic Dermatitis

  • The Pharma Data
  • February 28, 2026

Organon Presents Data on VTAMA Cream’s Impact on Sleep at AAAAI 2026 Annual Meeting How can we address the significant sleep disturbances that affect children with atopic dermatitis and their…

Read MoreVTAMA Cream Shows Early and Consistent Sleep Improvements in Pediatric Atopic Dermatitis
BlueWind Medical
  • News

BlueWind Medical Sets New Standard in Implantable Tibial Neuromodulation with Revi® System

  • The Pharma Data
  • February 28, 2026

Three-Year Data Confirm Revi’s Unmatched Durability and Patient Satisfaction Why is the treatment of urgency urinary incontinence (UUI) still a significant challenge for healthcare providers? BlueWind Medical, a leader in…

Read MoreBlueWind Medical Sets New Standard in Implantable Tibial Neuromodulation with Revi® System
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial for Manganese MRI Contrast Agent
  • Ironwood Pharmaceuticals to Present HCP Insights on TPN Burden in Short Bowel Syndrome at Digestive Disease Week® 2026
  • Bausch + Lomb Publishes Review on B Vitamins and AMD Risk Reduction
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.